CareDx Debt to Equity Ratio 2013-2023 | CDNA
Current and historical debt to equity ratio values for CareDx (CDNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CareDx debt/equity for the three months ending December 31, 2023 was 0.00.
| CareDx Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.21B | $0.26B | 0.79 |
| 2023-09-30 | $0.11B | $0.39B | 0.27 |
| 2023-06-30 | $0.11B | $0.41B | 0.27 |
| 2023-03-31 | $0.11B | $0.42B | 0.26 |
| 2022-12-31 | $0.11B | $0.43B | 0.26 |
| 2022-09-30 | $0.11B | $0.44B | 0.25 |
| 2022-06-30 | $0.10B | $0.44B | 0.22 |
| 2022-03-31 | $0.09B | $0.46B | 0.20 |
| 2021-12-31 | $0.10B | $0.47B | 0.22 |
| 2021-09-30 | $0.09B | $0.47B | 0.19 |
| 2021-06-30 | $0.08B | $0.48B | 0.16 |
| 2021-03-31 | $0.07B | $0.47B | 0.15 |
| 2020-12-31 | $0.09B | $0.28B | 0.33 |
| 2020-09-30 | $0.09B | $0.27B | 0.32 |
| 2020-06-30 | $0.08B | $0.26B | 0.32 |
| 2020-03-31 | $0.06B | $0.10B | 0.55 |
| 2019-12-31 | $0.05B | $0.10B | 0.53 |
| 2019-09-30 | $0.05B | $0.10B | 0.49 |
| 2019-06-30 | $0.05B | $0.09B | 0.53 |
| 2019-03-31 | $0.03B | $0.10B | 0.34 |
| 2018-12-31 | $0.04B | $0.10B | 0.36 |
| 2018-09-30 | $0.05B | $0.04B | 1.06 |
| 2018-06-30 | $0.05B | $0.03B | 1.76 |
| 2018-03-31 | $0.05B | $0.03B | 1.36 |
| 2017-12-31 | $0.09B | $-0.01B | -15.04 |
| 2017-09-30 | $0.08B | $0.00B | -430.10 |
| 2017-06-30 | $0.07B | $0.01B | 5.49 |
| 2017-03-31 | $0.07B | $0.02B | 4.41 |
| 2016-12-31 | $0.06B | $0.02B | 2.88 |
| 2016-09-30 | $0.07B | $0.04B | 1.78 |
| 2016-06-30 | $0.07B | $0.03B | 2.09 |
| 2016-03-31 | $0.03B | $0.02B | 1.39 |
| 2015-12-31 | $0.03B | $0.03B | 0.89 |
| 2015-09-30 | $0.03B | $0.03B | 0.75 |
| 2015-06-30 | $0.03B | $0.04B | 0.67 |
| 2015-03-31 | $0.02B | $0.04B | 0.60 |
| 2014-12-31 | $0.02B | $0.04B | 0.48 |
| 2014-09-30 | $0.02B | $0.04B | 0.53 |
| 2014-06-30 | $0.04B | $-0.00B | -24.19 |
| 2014-03-31 | $0.03B | $-0.02B | -1.66 |
| 2013-12-31 | $0.03B | $-0.02B | -1.64 |
| 2013-09-30 | $0.00B | $0.00B | 0.00 |
| 2013-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.02B | $-0.01B | -1.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.426B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.860B | 15.54 |
| Cencora (COR) | United States | $47.415B | 18.92 |
| ICON (ICLR) | Ireland | $25.281B | 24.93 |
| DiDi Global (DIDIY) | China | $23.464B | 0.00 |
| Avantor (AVTR) | United States | $17.398B | 23.97 |
| CochLear (CHEOY) | $13.726B | 0.00 | |
| Viatris (VTRS) | United States | $13.628B | 3.89 |
| Revvity (RVTY) | United States | $12.785B | 22.26 |
| Medpace Holdings (MEDP) | United States | $12.615B | 41.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.511B | 0.00 |
| Charles River Laboratories (CRL) | United States | $12.369B | 22.55 |
| Natera (NTRA) | United States | $10.994B | 0.00 |
| Solventum (SOLV) | United States | $10.955B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.218B | 20.07 |
| Organon (OGN) | United States | $4.734B | 4.58 |
| Doximity (DOCS) | United States | $4.585B | 34.14 |
| PACS (PACS) | United States | $3.659B | 0.00 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Surgery Partners (SGRY) | United States | $3.213B | 29.86 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Premier (PINC) | United States | $2.520B | 9.22 |
| Teladoc Health (TDOC) | United States | $2.326B | 0.00 |
| Agilon Health (AGL) | United States | $2.195B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.166B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.832B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.364B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.790B | 8.17 |
| Embecta (EMBC) | United States | $0.626B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.440B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.397B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 58.33 |
| MultiPlan (MPLN) | United States | $0.361B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.323B | 0.00 |
| ModivCare (MODV) | United States | $0.320B | 4.24 |
| GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.285B | 0.00 |
| Sharecare (SHCR) | United States | $0.262B | 0.00 |
| Biodesix (BDSX) | United States | $0.124B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |